Legend Biotech Corporation (NASDAQ:LEGN) Q4 2024 Earnings Call Transcript March 11 ... track and we continue to maintain a ...

Earnings per share (EPS) also surpassed analyst estimates by 32%. Looking ahead, revenue is forecast to grow 27% p.a. on average during the next 3 years, compared to a 20% growth forecast for the ...

Legend Biotech shares dipped 0.8% following the earnings release, suggesting a relatively muted market reaction to the results. This article was generated with the support of AI and reviewed by an ...

Legend Biotech Corporation Sponsored ADR (LEGN ... watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine ...

HC Wainwright also issued estimates for Legend Biotech’s Q2 2025 earnings at $0.06 EPS, Q3 2025 earnings at ($0.06) EPS and FY2025 earnings at ($0.07) EPS. Get Legend Biotech alerts: ...

Both types of dividend reduce retained earnings and impact shareholders' equity. However, only cash dividends reduce cash on the balance sheet. Retained earnings represent the cumulative net ...